Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ARM vs MCHPP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ARM Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 4–5 Matrix Metrics)

ARM Overall Winner 6-Pillar Tally: ARM 3 – 3 MCHPP Matrix Metrics: ARM 4 – 5 MCHPP

As of Nov 16, 2026, Arm Holdings plc (ARM) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). ARM carries a Unified Composite Score of 54.3/100 (HOLD) at $177.10 (89.1x Forward P/E, 17.0% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).

  • Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ARM 54.3/100 HOLD), ARM captures the overall institutional head-to-head verdict (4–5 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (17.0% vs. 21.6% operating margin) and revenue trajectory (+27.1% vs. +42.2% YoY).
  • Technical & Structure Timing Caution: ARM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ARM vs MCHPP
ARM NASDAQ Head-to-Head Winner
Arm Holdings plc American Depositary Shares
Semiconductors & Related Devices
$177.10
-7.05% 1D
Market Cap $213.8B
TTM Revenue $5.46B
Forward P/E 89.1x
Beta / 30D Vol 4.00β · 96% Vol
Unified Composite Score
54.3 / 100 HOLD
Tech 50.0 Fund 59.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.6%), weak momentum, RSI 37
RSI-14: 36.8 · SMA20: $202.97 · SMA50: $246.64
MCHPP NASDAQ
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Semiconductors & Related Devices
$52.64
-3.18% 1D
Market Cap N/A
TTM Revenue $5.60B
Forward P/E N/M
Beta / 30D Vol 2.16β · 65% Vol
Unified Composite Score
57.1 / 100 HOLD
Tech 74.0 Fund 61.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.8%), weak momentum, RSI 32
RSI-14: 32.3 · SMA20: $61.25 · SMA50: $63.22

6-Pillar Scorecard Institutional Category Breakdown (ARM 3 – 3 MCHPP)

Columns: Metric · ARM · MCHPP
1. Valuation Multiples ARM
Forward P/E 89.1x N/M
Trailing P/E N/M N/M
PEG Ratio 1.68x N/M
EV / Revenue 38.6x N/M
2. Growth & Scale MCHPP
Revenue Growth (YoY) +27.1% +42.2%
Earnings Growth (YoY) -45.5% N/A
TTM Revenue (USD) $5.46B $5.60B
Market Cap $213.8B N/A
3. Profitability & Quality MCHPP
Gross Margin 97.4% 62.7%
Operating Margin 17.0% 21.6%
Net Profit Margin 17.1% 15.0%
Return on Equity (ROE) 11.3% 12.6%
4. Balance Sheet & Cash Flow MCHPP
Cash Generation (TTM) $1.18B $1.87B EBITDA
Cash Flow Margin 21.5% 33.3% EBITDA Mgn
Net Cash / Leverage $2.75B Net Cash $12.20 Book/Sh · 12.6% ROE
Dividend Yield None (0.00%) 6.84%
5. Options & Positioning ARM
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 90.6% (73rd %ile) N/A (N/A)
Put/Call OI Skew 1.91x (Put-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ARM
OpEx & R&D Intensity 80.4% of Rev ($4.39B) 41.1% of Rev ($2.30B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Ecosystem & Network-Effect Moat Scale & Operating Efficiency Moat
Supply-Chain Role Compute Architecture Licensing & Royalty Leader Semiconductors Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ARM (4) vs MCHPP (5)
Institutional Metric ARM MCHPP Criterion Row Edge
Market Capitalization
Scale
$213.8B N/A Larger Scale ARM
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
89.1x N/M Lower Multiple ARM
Revenue Growth (YoY)
Growth
+27.1% +42.2% Higher Growth MCHPP
Operating Margin (TTM)
Profitability
17.0% 21.6% Higher Margin MCHPP
Net Profit Margin
Profitability
17.1% 15.0% Higher Margin ARM
Return on Equity (ROE)
Capital Efficiency
11.3% 12.6% Higher ROE MCHPP
52-Week Range Position
Momentum
22% ($100–$453) 14% ($47–$88) Stronger Trend ARM
Beta / 30D Volatility
Risk Regime
4.00β · 96% Vol 2.16β · 65% Vol Lower Realized Risk MCHPP
Unified Institutional Score
Composite Signal
54.3 / 100 (HOLD) 57.1 / 100 (HOLD) Higher Composite MCHPP
Trailing 12M Revenue (USD)
Operating Scale
$5.46B $5.60B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
97.4% 62.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.68x PEG · 38.6x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.18B ($2.75B Net Cash) $1.87B EBITDA ($12.20 Book/Sh · 12.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MCHPP +4.85 pp
ARM: -22.26% · MCHPP: -17.41%
3M Horizon MCHPP +8.66 pp
ARM: -30.09% · MCHPP: -21.43%
6M Horizon ARM +15.67 pp
ARM: -17.67% · MCHPP: -33.34%
1Y Horizon ARM +25.42 pp
ARM: +26.22% · MCHPP: +0.8%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARM vs MCHPP. Trailing 12-month operating profitability (ARM 17.0% vs MCHPP 21.6%) and valuation multiples (ARM 89.1x vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ARM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.46B
Gross Margin97.4%
Op. Margin17.0%
ROE / Fwd P/E11.3% · 89.1x
MCHPP ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.60B
Gross Margin62.7%
Op. Margin21.6%
ROE / Fwd P/E12.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ARM BREAKDOWN
115d in phase · OBV NEUTRAL
Current IV 90.6%
IV Percentile 73rd %ile
Put/Call OI Skew 1.91x (Put-Skewed)
IV Regime Elevated (60th–80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ARM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MCHPP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MCHPP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ARM Moat Profile Ecosystem & Network-Effect Moat
Compute Architecture Licensing & Royalty Leader
Per-chip architecture royalties scale with leading-edge mobile SoC and custom cloud/AI host CPU wafer shipments.
OpEx & R&D Reinvestment 80.4% of Rev ($4.39B)
90D Engineering Disclosures 0 Published · Edge AI / Inference Chips
Mapped Supply-Chain Ecosystem (16 partners):
Synopsys Cadence Design Systems Siemens EDA Taiwan Semiconductor Manufacturing Company
MCHPP Moat Profile Scale & Operating Efficiency Moat
Semiconductors Operator
Competes within the Semiconductors value chain with N/A market capitalization and 21.6% operating margin.
OpEx & R&D Reinvestment 41.1% of Rev ($2.30B)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (19 partners):
Taiwan Semiconductor Manufacturing Company United Microelectronics Corporation Amkor Technology ASE Technology Holding

Investor FAQ ARM vs MCHPP Key Questions & Quantitative Answers

As of Nov 16, 2026, Arm Holdings plc (ARM) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Options & Positioning, R&D & Supply-Chain Moat). ARM carries a Unified Composite Score of 54.3/100 (HOLD) at $177.10 (89.1x Forward P/E, 17.0% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. ARM 54.3/100 HOLD), ARM captures the overall institutional head-to-head verdict (4–5 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (17.0% vs. 21.6% operating margin) and revenue trajectory (+27.1% vs. +42.2% YoY). Technical & Structure Timing Caution: ARM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.8); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MCHPP leads the Growth & Scale pillar: ARM posts +27.1% YoY revenue growth and -45.5% YoY earnings growth on $5.46B TTM revenue (97.4% gross margin, 17.0% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, ARM generates $5.46B in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, ARM deploys 80.4% of Rev ($4.39B) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.

ARM screens cheaper on headline valuation multiples. ARM trades at 89.1x Forward P/E, N/M Trailing P/E, 1.68x PEG, and 38.6x EV/Revenue (21.5% FCF margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARM (11.3% ROE) versus MCHPP (12.6% ROE) capital efficiency.

In options market volatility and institutional positioning, ARM carries 90.6% implied volatility (73rd %ile, Elevated (60th–80th %ile)), a 1.91x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (4.00β · 96% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Arm Holdings plc American Depositary Shares (ARM) Research Suite

Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.